Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026)
Bausch Health Companies (BHC) reported Share-based Compensation of $34.0 million for Q1 2026, down 20.93% on a YoY basis from $43.0 million in Q1 2025, and down 82.29% sequentially from $192.0 million in Q4 2025.
Bausch Health Companies (BHC) Share-based Compensation (2009 - 2026) Analysis & Trends
Bausch Health Companies (BHC) has 18 years of Share-based Compensation data on file, last reported at $34.0 million in Q1 2026.
- For the quarter ending Q1 2026, Share-based Compensation fell 20.93% year-over-year to $34.0 million; the trailing twelve-month figure through Mar 2026 stood at $207.0 million (up 29.37% YoY), and the FY2025 full-year result was $216.0 million, up 44.0% from the prior year.
- Share-based Compensation eased to $34.0 million in Q1 2026, from $192.0 million in the prior quarter.
- In the past five years, Share-based Compensation ranged from a high of $192.0 million in Q4 2025 to a low of -$65.0 million in Q3 2025.
- A 5-year average of $33.1 million and a median of $33.0 million in 2023 frame the typical range for Share-based Compensation.
- Across the five-year window, Share-based Compensation soared 10800.0% in 2023 and slumped 1400.0% in 2025, its largest moves.
- Tracing BHC's Share-based Compensation over 5 years: stood at $1.0 million in 2022, then soared by 10800.0% to $109.0 million in 2023, then rose by 16.51% to $127.0 million in 2024, then surged by 51.18% to $192.0 million in 2025, then sank by 82.29% to $34.0 million in 2026.
- Business Quant data shows BHC's Share-based Compensation at $34.0 million in Q1 2026, $192.0 million in Q4 2025, and -$65.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Share-based Compensation (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 43.00 Mn |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | 25.00 Mn |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | 125.69 Mn |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | 58.30 Mn |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 56.50 Mn |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 55.70 Mn |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 21.00 Mn |
| 10 | Bausch Health Companies | 1.66 Bn | 1.33 Bn | 2.52 Bn | 34.00 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 34.00 Mn |
| Mar 31, 2026 | 34.00 Mn |
| Dec 31, 2025 | 192.00 Mn |
| Dec 31, 2025 | 192.00 Mn |
| Sep 30, 2025 | -65.00 Mn |
| Sep 30, 2025 | -65.00 Mn |
| Jun 30, 2025 | 46.00 Mn |
| Jun 30, 2025 | 46.00 Mn |
| Mar 31, 2025 | 43.00 Mn |
| Mar 31, 2025 | 43.00 Mn |
| Dec 31, 2024 | 127.00 Mn |
| Dec 31, 2024 | 127.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Sep 30, 2024 | 5.00 Mn |
| Jun 30, 2024 | -15.00 Mn |
| Jun 30, 2024 | -15.00 Mn |
| Mar 31, 2024 | 33.00 Mn |
| Mar 31, 2024 | 33.00 Mn |
| Dec 31, 2023 | 109.00 Mn |
| Dec 31, 2023 | 109.00 Mn |